Raymond James Financial’s IRIDEX IRIX Stock Holding History

Raymond James Financial’s Portfolio IRIX Stock Details IRIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-700	Closed	-$617	–	5830
2025 Q2	$617	Buy	+700	New	+$713	﹤0.01%	6645

Other funds holding IRIX

PAPAIJV

Paragon Associates & Paragon Associates II Joint Venture Dallas, Texas $73.6M AUM 61.93% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

AMH Equity Great Neck, New York $80.3M AUM 78.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Apexium Financial Dallas, Texas $2.06B AUM 15.96% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Raymond James Financial's IRIX Position: Q3 2025 in Review

Raymond James Financial sold out of IRIDEX (IRIX) in Q3 2025, closing a stake of 700 shares — an estimated $617 sold.

Raymond James Financial first reported a position in IRIX in Q2 2025 and held it in 1 quarter. The position peaked at $617 in Q2 2025. 22 funds tracked by Wall St. Rank hold IRIX as of Q3 2025.

Raymond James Financial reported no remaining IRIDEX position as of Q3 2025 after selling out during the quarter.
Raymond James Financial sold 700 IRIDEX shares in Q3 2025, an estimated $617.
Raymond James Financial first reported a position in IRIDEX in Q2 2025 and held it in 1 quarter.
Raymond James Financial's IRIDEX position peaked at $617 in Q2 2025.
22 funds tracked by Wall St. Rank held IRIDEX as of Q3 2025.

Based on Raymond James Financial's 13F filing for Q3 2025, filed 14 Nov 2025.